Global Cord Blood (NYSE:CO) and Paya (NASDAQ:PAYA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.
Risk and Volatility
Global Cord Blood has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Paya has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500.
Profitability
This table compares Global Cord Blood and Paya's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Global Cord Blood | 42.17% | 12.77% | 6.91% |
Paya | N/A | -1.98% | -0.03% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for Global Cord Blood and Paya, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Global Cord Blood | 0 | 0 | 0 | 0 | N/A |
Paya | 0 | 0 | 5 | 0 | 3.00 |
Paya has a consensus price target of $15.75, suggesting a potential upside of 39.38%. Given Paya's higher possible upside, analysts clearly believe Paya is more favorable than Global Cord Blood.
Valuation & Earnings
This table compares Global Cord Blood and Paya's gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Global Cord Blood | $172.50 million | 3.39 | $66.48 million | N/A | N/A |
Paya | N/A | N/A | $4.28 million | $0.18 | 63.17 |
Global Cord Blood has higher revenue and earnings than Paya.
Institutional and Insider Ownership
41.2% of Paya shares are held by institutional investors. 1.5% of Paya shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Global Cord Blood beats Paya on 6 of the 11 factors compared between the two stocks.